Given the success of recent picks lately (DLTR, BIG, TROX), I wanted to share another intriguing short setup, which is Acadia Pharmaceuticals. Its topping pattern right now seems to mirror perfectly its basing pattern from years ago. I anticipate much lower prices in the months ahead. Apparently, their big product is a drug that combats hallucinations. This market could sure use some of those pills.
Leave A Comment